The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab in combination with axitinib (Ave + Axi) for first-line (1L) treatment of advanced renal cell carcinoma (aRCC): A systematic literature review (SLR) of real-world effectiveness and safety.
 
Mairead Kearney
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA; Novartis; UCB
 
Ankush Taneja
Employment - Lumanity
Research Funding - Merck KGaA (Inst)
 
Aniket Sharma
Employment - Lumanity
Research Funding - Merck KGaA (Inst)
 
Ahmed Elsada
Employment - Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany
 
Anna-Maria Fontrier
Employment - Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany
 
Stamatia Alexopoulos
Employment - Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany
 
Neil Roskell
Employment - Lumanity
Research Funding - Merck KGaA (Inst)